Study Evaluating IMA-638 in Healthy Japanese

Wyeth is now a wholly owned subsidiary of Pfizer

Overview

The purpose of this study is to evaluate the safety and drug levels for single, ascending doses of IMA-638 in healthy Japanese subjects.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

DIAGNOSTIC

Masking

DOUBLE

Sex: ALLMin age: 20 YearsMax age: 45 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * First generation healthy Japanese men and women of non-childbearing potential.

Unnamed facility

Glendale, California, United States

Safety will be measured by evaluating physical examinations, vital signs, electrocardiograms (ECGs), and clinical laboratory test results.

Drug levels and associated biomarkers will be evaluated.

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.